U S Physical Therapy (USPH) Cash & Equivalents (2010 - 2026)

U S Physical Therapy has disclosed Cash & Equivalents across 17 years of filings, most recently posting $28.4 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $28.4 million, down 27.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.4 million (down 27.42% YoY), and the FY2025 annual result was $35.6 million, down 14.0% from the prior year.
• Cash & Equivalents came in at $28.4 million for Q1 2026 at U S Physical Therapy, down from $35.6 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $160.7 million in Q2 2023 to a low of $24.2 million in Q1 2022.
• The 5-year median for Cash & Equivalents is $39.2 million (2025), against an average of $71.1 million.
• Across the five-year window, Cash & Equivalents surged 383.72% in 2023 and sank 73.41% in 2025, its largest moves.
• U S Physical Therapy's Cash & Equivalents stood at $31.6 million in 2022, then soared by 383.72% to $152.8 million in 2023, then sank by 72.94% to $41.4 million in 2024, then declined by 14.0% to $35.6 million in 2025, then decreased by 20.05% to $28.4 million in 2026.
• The last three Cash & Equivalents figures came in at $28.4 million (Q1 2026), $35.6 million (Q4 2025), and $31.1 million (Q3 2025), per Business Quant data.